Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-25 @ 11:24 PM
Study NCT ID:
NCT05194293
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-04
First Post:
2021-12-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
Sponsor:
Academic and Community Cancer Research United
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-02
First Submit QC Date:
None
Study First Post Date:
2022-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-09-04
Last Update Post Date Type:
ESTIMATED